Browsing by Author Sy, Oumar
Showing results 1 to 2 of 2
Issue Date | Title | Author(s) |
2018 | Dasatinib Versus Imatinib in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Not Achieved an Optimal Response to 3 Months of Imatinib Therapy: Dascern | Cortes, Jorge E.; Jiang, Qian; Wang, Jianxiang; Weng, Jianyu; Zhu, Huanling; Liu Xiaoli; Hochhaus, Andreas; Kim, Dong-Wook; Radich, Jerald; Savona, Michael R.; Regueira, Patricia Martin; Sy, Oumar; Gurnani, Renuka; Saglio, Giuseppe |
Apr-2020 | Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study | Cortes, Jorge E.; Jiang, Qian; Wang, Jianxiang; Weng, Jianyu; Zhu, Huanling; Liu, Xiaoli; Hochhaus, Andreas; Kim, Dong-Wook; Radich, Jerald; Savona, Michael; Martin-Regueira, Patricia; Sy, Oumar; Gurnani, Renuka; Saglio, Giuseppe |